Antiproliferative effects on non-small cell lung cancer cells by combining Tamoxifen and Gefitinib;

Experimental study on β-elemene combined with tamoxifen inhibiting the apoptosis of breast cancer cell strain MCF-7;

Reversal of adraimycin-resistance in ovarian carcinoma cells by verapamil and tamoxifen in vitro;

Pro-apoptotic effects of Vitamin D_3 and Tamoxifen on breast cancer cells and associated mechanism;

Effect of 1,25-dihydroxyvitamin D_3 and Tamoxifen on cell cycle distribution and apoptosis of MDA-MB-231 cells transfected with ERα expression vector containing vitamin D response element;

Effects of tamoxifen on biomechanical properties of bone in ovariectomized rats;

Antisense hTR combined with Tamoxifen increase the inhibitory effect on growth of glioma cells;

Influence of tamoxifen on the level of cellular proliferation on cultured human pituitary adenoma cells and its mechanism;

Influence of Tamoxifen on the level of cellular proliferation of cultured human prolactinoma cells and its mechanism;

Objective: To identify the effect of oestrogen receptor (ER) antagonist, tamoxifen, combination with EGFR tyrosine kinase inhibitor, gefitinib, on the proliferation and apoptosis in non-small cell lung cancer (NSCLC) cell lines and the related molecular mechanism, providing theoretical evidence for the molecular targeted treatment combination with endocrine treatment in NSCLC.

Tamoxifen inhibits the growth of ER negative thyroid carcinomas in vitro and in vivo;

An Experimental Study of the Inhibition of Tamoxifen on Rat Model of Benign Prostatic Hyperplasia;

Study on the reversing effect of tamoxifen on multidrug resistant cell line K562/DOX;

Reversing Effect of Tamoxifen and Cydosporine A on Multidrug Resistant Cell Line K562/DOX;